tirzepatide mash fda Eli Lilly's Shows Promise in Treating Fatty Liver Disease FDA Approval Expands Novo Nordisk's

Verified against PubMed, Oxford Academic, and the 2025 correction notice (Aesthet Surg J 2025 Jun 16;45(7):754, doi:10.1093/asj/sjaf039) that emended the third co-author's name to "Raheel Zubair." Source for the anatomical pattern of compartment-specific losses (medial cheek, sub-orbicularis oculi, temporal fat pads)

40% reduced -cell mass in DM2 (Maheshvare et al., 2023)

Now, a study carried out by the research group "Mitochondrial regulation of cell death" published in Gastroenterology with Sandra Torres as the first signatory and coordinated by Carmen Garcia Ruiz and Jose C Fernandez-Checa, has identified a new actor in the mitochondrial scene which plays a fundamental role in the hepatotoxicity induced either by paracetamol by itself or in combination with valproic acid (VPA), an antiepileptic

Early findings suggest reduced cravings and improved impulse control in some patients, although this area continues to be studied and is not yet considered a standard treatment for addiction

Kitada, K